DV
Dividend Vision

BCAX — Bicara Therapeutics Inc.

Bicara Therapeutics Inc. (BCAX)

Total return is 34.9% over the past 1.9 years, 7.2 points behind SPY at 42.1%. Its deepest 1-year drawdown was 26.4%.

BCAX is an equity stock that commenced trading in September 2024. The fund does not currently distribute dividends and therefore carries no yield profile. This holding appeals primarily to growth-oriented investors rather than those seeking current income.

BCAX key facts

Asset type
Stock
Asset class
Equity
Inception date
09/12/2024
Distribution frequency
None
Last close
$24.28
Market cap
$1,606,678,912
Average volume
479900.0
Payout ratio
0.0
Forward P/E
0.0
EPS
$-3.17